The development and launch of a new, original drug is a significant event in the life of every pharmaceutical company and an important step forward in the treatment of certain diseases. This is also why original research is of great importance in the implementation of Gedeon Richter's strategy. Our researchers are committed to working on projects that bring new, innovative therapies to patients worldwide.
0
staff
0
projects in the pipeline
0
% of revenue spent on R and D
0
Innovation Grand Prix
0
"Medicine of the Year" in Hungary